CN104397676A - 一种解酒保肝护肝的保健食品 - Google Patents
一种解酒保肝护肝的保健食品 Download PDFInfo
- Publication number
- CN104397676A CN104397676A CN201410651027.7A CN201410651027A CN104397676A CN 104397676 A CN104397676 A CN 104397676A CN 201410651027 A CN201410651027 A CN 201410651027A CN 104397676 A CN104397676 A CN 104397676A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- liver
- alcohol
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 210000004185 liver Anatomy 0.000 title claims abstract description 15
- 230000000694 effects Effects 0.000 title abstract description 12
- 235000013305 food Nutrition 0.000 title abstract 4
- 239000000284 extract Substances 0.000 claims abstract description 48
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 6
- 244000248825 Peltandra virginica Species 0.000 claims abstract description 6
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 6
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 6
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 6
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 6
- 239000008103 glucose Substances 0.000 claims abstract description 6
- 229960003080 taurine Drugs 0.000 claims abstract description 6
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 6
- 239000011718 vitamin C Substances 0.000 claims abstract description 6
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 6
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 6
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 6
- 235000013402 health food Nutrition 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 6
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 6
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 240000008866 Ziziphus nummularia Species 0.000 claims description 4
- 229940010454 licorice Drugs 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000007902 hard capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 5
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract description 5
- 241001573260 Amomum krervanh Species 0.000 abstract 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 2
- 229930182816 L-glutamine Natural products 0.000 abstract 2
- 229930003451 Vitamin B1 Natural products 0.000 abstract 2
- 229940002508 ginger extract Drugs 0.000 abstract 2
- 235000020708 ginger extract Nutrition 0.000 abstract 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 2
- 235000011477 liquorice Nutrition 0.000 abstract 2
- 229960003495 thiamine Drugs 0.000 abstract 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 2
- 235000010374 vitamin B1 Nutrition 0.000 abstract 2
- 239000011691 vitamin B1 Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 3
- 241000202807 Glycyrrhiza Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- DCTLJGWMHPGCOS-UHFFFAOYSA-N Osajin Chemical compound C1=2C=CC(C)(C)OC=2C(CC=C(C)C)=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DCTLJGWMHPGCOS-UHFFFAOYSA-N 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- OUZCFMSJGDEXRT-UHFFFAOYSA-N Scandinone Natural products O=C1C=2C(OC)=C(CC=C(C)C)C=3OC(C)(C)C=CC=3C=2OC=C1C1=CC=C(O)C=C1 OUZCFMSJGDEXRT-UHFFFAOYSA-N 0.000 description 2
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical compound C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 description 2
- 239000007887 hard shell capsule Substances 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229930186669 gynosaponin Natural products 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及一种用于解酒保肝护肝的保健食品，其各组分重量份数分别为：绞股蓝提取物8-12份、葛根提取物6-10份、砂仁提取物2-6份、豆寇提取物2-6份、甘草提取物1-3份、干姜提取物1-3份、茯苓提取物1-2份、陈皮提取物1-2份、酸枣仁提取物1-2份、葡萄糖0.5-4份、L-谷氨酰胺0.1-0.5份、牛磺酸0.01-0.04份、葡萄糖酸锌0.001-0.005份、维生素C0.0001-0.0005份、维生素B10.0001-0.0002份。本发明所选取的绞股蓝提取物、葛根提取物、砂仁提取物、豆寇提取物、甘草提取物、干姜提取物、茯苓提取物、陈皮提取物、酸枣仁提取物、葡萄糖、L-谷氨酰胺、牛磺酸、葡萄糖酸锌、维生素C份、维生素B1配比，其配料科学合理，共同作用能起到解酒保肝护肝的作用。
Description
技术领域
本发明涉及一种保健食品，尤其是一种用于解酒保护肝脏的保健食品。
背景技术
近年来，随着我国人均酒精消耗量的显著增长，酒精性肝病的发病率也逐年增高，在一些地区甚至已成为第二大肝病。
酒精性肝病是人体摄入乙醇后所引起的一种以肝脏损伤为特点的常见病。由于乙醇是一种中枢神经抑制品，具有神经细胞毒作用，长期大量饮用可引起神经及心理认知功能损害，因此它已成为继病毒性肝炎后导致肝损害的第二大病因。
研究结果显示：我国酒精性肝病患者饮酒年限久，日饮用量大。在902例酒精性肝病患者中，平均饮酒年限为22.4年，平均日摄入乙醇量128.9克，日饮量最大为640克；酒精性肝病的发病率呈逐年梯次上升；我国酒精性肝病患者肝脏损伤严重，其中酒精性肝炎患者占28.8%，酒精性肝硬化患者占37.4%。
发明内容
本发明提供一种解酒保肝护肝的保健食品，可用于保护肝脏解除酒精的伤害。
本发明是以如下技术方案实现的：一种解酒保肝护肝的保健食品，其特征在于它由下述重量份数的原料共同混合加工制成：绞股蓝提取物8-12份、葛根提取物6-10份、砂仁提取物2-6份、豆寇提取物2-6份、甘草提取物1-3份、干姜提取物1-3份、茯苓提取物1-2份、陈皮提取物1-2份、酸枣仁提取物1-2份、葡萄糖0.5-4份、L-谷氨酰胺0.1-0.5份、牛磺酸0.01-0.04份、葡萄糖酸锌0.001-0.005份、维生素C0.0001-0.0005份、维生素B10.0001-0.0002份。
本发明还公开一种颗粒剂、片剂、硬胶囊剂、软胶囊剂、口服液，用前述原料加入辅料经相应工艺制得。
绞股蓝，味苦；微甘；性凉。可治疗高血压、高血脂、高血糖，脂肪肝等症，有保肝解毒、降血压、降血脂血糖的功效。绞股蓝主要有效成份是绞股蓝皂甙、绞股蓝糖甙(多糖)、水溶性氨基酸、黄酮类、多种维生素、微量元素、矿物质等。
葛根主要含异黄酮类之葛根素和三萜类葛皂醇等成分，异黄酮类含有葛根素、葛根木糖苷、大豆黄酮苷、金雀异黄素、芒柄黄花素、拟雌内酯、异甘草素等二十多种异黄酮类成分。具有醒酒解酒的作用，适用于饮酒过量及出现酒精轻度中毒症状者。
本发明在传统食疗的基础上，搭配新食品原料，科学配伍，服用方便。各原料的有效因子充分发挥协同增效作用，起到解酒保护肝脏的作用，安全无毒副作用。
本发明的有益效果是：本发明是一种解酒保肝护肝的保健食品，该配方是严格按照中医理论和现代养生学科学拟定，整个组方合理、严谨，可制备成多种剂型的保健食品，原料易得，制备工艺相对简单，成本能够得以控制。
具体实施方式
下面结合实施例对本发明做进一步描述。
实施例1
一种解酒保肝护肝的保健食品，该保健食品制备成硬胶囊，其组分及重量份数为：绞股蓝提取物12份、葛根提取物10份、砂仁提取物6份、豆寇提取物6份、甘草提取物3份、干姜提取物3份、茯苓提取物2份、陈皮提取物2份、酸枣仁提取物2份、葡萄糖4份、L-谷氨酰胺0.5份、牛磺酸0.04份、葡萄糖酸锌0.005份、维生素C0.0005份、维生素B10.0002份。将上述原料混合均匀，通过硬胶囊自动填充设备填充到胶囊壳中，制成硬胶囊剂。
按照实施例配方，1000人进行试用，其中952人认为本发明在解酒保肝护肝方面具有显著的保健作用，满意率高达95.2%。
实施例2
一种解酒保肝护肝的保健食品，该保健食品制备成片剂，其组分及重量份数为：绞股蓝提取物10份、葛根提取物8份、砂仁提取物4份、豆寇提取物3份、甘草提取物2份、干姜提取物2份、茯苓提取物1份、陈皮提取物1份、酸枣仁提取物1份、葡萄糖3份、L-谷氨酰胺0.3份、牛磺酸0.02份、葡萄糖酸锌0.003份、维生素C0.0001份、维生素B10.0001份。将上述原料加入一定量的羧甲基淀粉钠，制粒后，压成素片，包衣，得到片剂。
按照实施例配方，1000人进行试用，其中933人认为本发明在解酒保肝护肝方面具有显著的保健作用，满意率高达93.3%。
以上对本发明进行了详细介绍，以上实施例的说明只是用于帮助理解本发明。本领域的普通技术人员应当理解，可以对本发明的技术方案进行更动、润饰或者等同替换，而不脱离本发明技术方案的精神和范围，其均应属于本发明的权利要求保护范围当中。
Claims (2)
1.一种解酒保肝护肝的保健食品，其特征在于它由下述重量份数的原料共同混合加工制成：绞股蓝提取物8-12份、葛根提取物6-10份、砂仁提取物2-6份、豆寇提取物2-6份、甘草提取物1-3份、干姜提取物1-3份、茯苓提取物1-2份、陈皮提取物1-2份、酸枣仁提取物1-2份、葡萄糖0.5-4份、L-谷氨酰胺0.1-0.5份、牛磺酸0.01-0.04份、葡萄糖酸锌0.001-0.005份、维生素C0.0001-0.0005份、维生素B10.0001-0.0002份。
2.一种解酒保肝护肝的保健食品，其特征在于，权利要求1的原料加入辅料经相应工艺制得的颗粒剂、片剂、硬胶囊剂、软胶囊剂、口服液。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410651027.7A CN104397676A (zh) | 2014-11-17 | 2014-11-17 | 一种解酒保肝护肝的保健食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410651027.7A CN104397676A (zh) | 2014-11-17 | 2014-11-17 | 一种解酒保肝护肝的保健食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104397676A true CN104397676A (zh) | 2015-03-11 |
Family
ID=52635398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410651027.7A Pending CN104397676A (zh) | 2014-11-17 | 2014-11-17 | 一种解酒保肝护肝的保健食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104397676A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106213511A (zh) * | 2016-07-26 | 2016-12-14 | 张韩 | 一种能够解酒保肝的中药制剂及其制备方法 |
| CN108421027A (zh) * | 2018-05-07 | 2018-08-21 | 深圳润邦之家生物科技有限公司 | 一种解酒护肝产品 |
| CN109758570A (zh) * | 2019-03-27 | 2019-05-17 | 汤臣倍健股份有限公司 | 一种对酒精性肝损伤具有辅助保护作用的组合物及其保健品、应用 |
| EP3616705A4 (en) * | 2017-08-03 | 2020-04-15 | Corporation Ilwonbio | COMPOSITION WITH AMOMUM VILLOSUM TO IMPROVE THE PREVENTION AND TREATMENT OF FATTY LIVER |
| CN113317504A (zh) * | 2020-02-29 | 2021-08-31 | 河北康平健康产业有限责任公司 | 一种解酒保肝的葛根组合物及其制备方法 |
-
2014
- 2014-11-17 CN CN201410651027.7A patent/CN104397676A/zh active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106213511A (zh) * | 2016-07-26 | 2016-12-14 | 张韩 | 一种能够解酒保肝的中药制剂及其制备方法 |
| EP3616705A4 (en) * | 2017-08-03 | 2020-04-15 | Corporation Ilwonbio | COMPOSITION WITH AMOMUM VILLOSUM TO IMPROVE THE PREVENTION AND TREATMENT OF FATTY LIVER |
| CN108421027A (zh) * | 2018-05-07 | 2018-08-21 | 深圳润邦之家生物科技有限公司 | 一种解酒护肝产品 |
| CN109758570A (zh) * | 2019-03-27 | 2019-05-17 | 汤臣倍健股份有限公司 | 一种对酒精性肝损伤具有辅助保护作用的组合物及其保健品、应用 |
| CN113317504A (zh) * | 2020-02-29 | 2021-08-31 | 河北康平健康产业有限责任公司 | 一种解酒保肝的葛根组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104397676A (zh) | 一种解酒保肝护肝的保健食品 | |
| CN104982599A (zh) | 一种植物凉茶浓缩液及低糖植物凉茶饮料 | |
| CN104431064A (zh) | 一种降糖茶及其制备方法 | |
| CN102204610B (zh) | 一种银杏保健茶 | |
| CN112336815A (zh) | 一种强体防癌调理三高抗衰老组合物及其应用 | |
| CN104173453A (zh) | 一种用于防治鸡传染性喉气管炎的中药组合物及其制备方法 | |
| CN103828983A (zh) | 一种杜仲保健茶 | |
| CN104161814B (zh) | 一种用于提高鸡产蛋量及蛋品质的中药组合物及制备方法 | |
| Jalili et al. | An overview of therapeutic potentials of Taraxacum officinale (dandelion): A traditionally valuable herb with a reach historical background | |
| CN109805395A (zh) | 一种保护肝脏的保健食品 | |
| KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
| CN104208339A (zh) | 一种用于治疗畜禽细菌性、病毒性疾病的中药组合物及其制备方法 | |
| CN108783292A (zh) | 富含抗氧化营养素的沙棘果皮肉粉复合物营养代餐粉及其制备方法 | |
| CN104116684B (zh) | 一种纯天然沐浴粉 | |
| KR101783549B1 (ko) | Dha 함유 피로회복 증진 보조식품용 조성물 수능단(수능원) 및 그 제조방법 | |
| CN101856385A (zh) | 含有紫锥菊提取物的组合物及其制备方法 | |
| KR101028073B1 (ko) | 혈액순환을 개선하여 신체 각 부위를 활성화 시키며 면역력을 증진시키는 작용 및 기전을 가진 조성물과 그 제조방법 | |
| Pradeepika et al. | Pharmacology and Phytochemistry of underexploited tuber crops: A review | |
| KR20140076260A (ko) | 대추를 이용한 양갱 및 그 제조방법 | |
| CN102987486A (zh) | 红枣番茄功能饮料 | |
| CN102613648A (zh) | 一种原生态竹锗营养液的制备方法 | |
| CN105963556A (zh) | 一种健胃益脾降血压的铁皮石斛药酒及其制备方法 | |
| Sharma et al. | Adaptogens: New Age Healing Gems for Physical Wellbeing | |
| CN105167013A (zh) | 一种榛子粕为原料制备的保健食品及工艺 | |
| Shalini et al. | Moringa oleifera-Nutritional rich functional food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150311 |
|
| WD01 | Invention patent application deemed withdrawn after publication |